Actinium Pharmaceuticals, Inc. (ATNM) vs Cel-Sci Corporation (CVM)
- Actinium Pharmaceuticals, Inc. ATNM 1.13 +6.60%
- Cel-Sci Corporation CVM 1.79 +2.87%
Actinium Pharmaceuticals, Inc. and Cel-Sci Corporation are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Cel-Sci Corporation are of similar size ($33.3M and $30.6M). Cel-Sci Corporation has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.1×. Actinium Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 2,731.2% against 20.8%. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs 0.00%) and the higher return on invested capital (0.00% vs −169.6%). Across the 17 metrics below, Actinium Pharmaceuticals, Inc. leads on 14 and Cel-Sci Corporation on 3.
Valuation
Profitability
| Metric | ATNM | CVM | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.71% | 0.00% | 65.16% |
| Operating margin | 27.20% | 0.00% | 0.00% |
| Net margin | 32.18% | 0.00% | 0.00% |
| Free cash flow margin | (66.16%) | 0.00% | 0.00% |
| Return on equity | 45.86% | (252.53%) | (56.36%) |
| Return on assets | 21.92% | (108.91%) | (48.04%) |
| Return on invested capital | 0.00% | (169.59%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack